Human papillomavirus vaccine: What are women most concerned about?

被引:8
作者
Chan, Karen K. L. [1 ]
Kwan, Tracy T. C. [1 ]
Yao, Tzy-Jyun [2 ]
Tam, Kar Fai [1 ]
Cheung, Annie N. Y. [3 ]
Ngan, Hextan Y. S. [1 ]
机构
[1] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Clin Trials Ctr, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
HPV vaccine; HPV vaccine perception; HPV vaccine questionnaire; HPV vaccine survey; human papillomavirus; PARTICLE VACCINE; CERVICAL-CANCER; YOUNG-WOMEN; SUSTAINED EFFICACY; CHINESE WOMEN; DOUBLE-BLIND; ATTITUDES; TYPE-18; ACCEPTABILITY; INFECTION;
D O I
10.1111/j.1447-0756.2011.01639.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: This study aims to investigate the areas of concerns that women have regarding human papillomavirus (HPV) vaccination. Material and Methods: A cross-sectional questionnaire survey was conducted in a convenience sample of 1450 women attending outpatient family planning clinics in Hong Kong to assess women's concerns regarding HPV vaccination. The associations between each demographic characteristics and the importance of various issues concerning the vaccine, such as short and long-term side-effects, side-effect affecting appearance, number of women who have had it, effectiveness, effect duration and cost were explored using chi(2) tests for comparison of proportions. Multiple binary logistic regression analysis was applied to further identify independent demographic characteristics which were significantly associated with each of these issues. Results: The top three factors that most women felt very important were vaccine effectiveness (45.4%), effect duration (44.0%) and long-term side-effects (43.7%). Education level significantly affected the degree of concerns in these areas (OR = 1.15, P < 0.001, 1.14, P < 0.001 and 1.09, P = 0.006, respectively) while income was significantly inversely associated with the importance of cost (OR = 0.92, P < 0.001) and effectiveness (OR = 0.95, P = 0.047). Conclusion: The above issues should be specifically addressed when vaccine information is given, bearing in mind the particular concerns in women with different socio-economic backgrounds.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 29 条
  • [1] Women's attitudes on human papillomavirus vaccination to their daughters
    Chan, Symphorosa Shing Chee
    Cheung, Tak Hong
    Lo, Wing Kit
    Chung, Tony Kwok Hung
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2007, 41 (02) : 204 - 207
  • [2] Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis
    Constantine, Norman A.
    Jerman, Petra
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2007, 40 (02) : 108 - 115
  • [3] Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine
    Dinh, Tri A.
    Rosenthal, Susan L.
    Doan, Ellis D.
    Trang, Tony
    Pham, Viet H.
    Tran, Benson D.
    Tran, Vinh D.
    Phan, G. A. Bao
    Chu, H. K. H.
    Breitkopf, Carmen Radecki
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2007, 40 (06) : 559 - 563
  • [4] Ferris Daron G, 2007, J Low Genit Tract Dis, V11, P166, DOI 10.1097/lgt.0b013e3180324114
  • [5] Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1
  • [6] Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
    Garland, Suzanne M.
    Hernandez-Avila, Mauricio
    Wheeler, Cosette M.
    Perez, Gonzalo
    Harper, Diane M.
    Leodolter, Sepp
    Tang, Grace W. K.
    Ferris, Daron G.
    Steben, Marc
    Bryan, Janine
    Taddeo, Frank J.
    Railkar, Radha
    Esser, Mark T.
    Sings, Heather L.
    Nelson, Micki
    Boslego, John
    Sattler, Carlos
    Barr, Eliav
    Koutsky, Laura A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) : 1928 - 1943
  • [7] Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
    Harper, DM
    Franco, EL
    Wheeler, C
    Ferris, DG
    Jenkins, D
    Schuind, A
    Zahaf, T
    Innis, B
    Naud, P
    De Carvalho, NS
    Roteli-Martins, CM
    Teixeira, J
    Blatter, MM
    Korn, AP
    Quint, W
    Dubin, G
    [J]. LANCET, 2004, 364 (9447) : 1757 - 1765
  • [8] Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
    Harper, DM
    Franco, EL
    Wheeler, CM
    Moscicki, AB
    Romonowski, B
    Roteli-Martins, CM
    Jenkins, D
    Schuind, A
    Clemens, SAC
    Dubin, G
    [J]. LANCET, 2006, 367 (9518) : 1247 - 1255
  • [9] Adults' knowledge and behaviors related to human papillomavirus infection
    Holcomb, B
    Bailey, JM
    Crawford, K
    Ruffin, MT
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE, 2004, 17 (01): : 26 - 31
  • [10] Hoover D R, 2000, Health Care Women Int, V21, P375